Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
Content published before 2002 is available via pay-per-view purchase only.
Subscribe:
Subscribe to Clinics in Laboratory MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Origin of celiac disease: how old are predisposing haplotypes?.World J Gastroenterol. 2012; 18: 5300-5304
- Coeliac disease. IV. An investigation into the injurious constituents of wheat in connection with their action on patients with coeliac disease.Acta Paediatr. 1953; 42: 223-231
- Anti-reticulin antibodies in childhood coeliac disease.Lancet. 1971; 2: 681-682
- Contribution of the MHC region to the familial risk of coeliac disease.J Med Genet. 1999; 36: 687-690
- Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer.J Exp Med. 1989; 169: 345-350
- Coeliac disease: dissecting a complex inflammatory disorder.Nat Rev Immunol. 2002; 2: 647-655
- Genetics of type 1A diabetes.N Engl J Med. 2009; 360: 1646-1654
- HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European Genetics Cluster on Celiac Disease.Hum Immunol. 2003; 64: 469-477
- T-cell response to gluten in patients with HLA-DQ2.2 reveals requirement of peptide-MHC stability in celiac disease.Gastroenterology. 2012; 142: 552-561
- Celiac disease: prevalence, diagnosis, pathogenesis and treatment.World J Gastroenterol. 2012; 18: 6036-6059
- Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study.Arch Intern Med. 2003; 163: 286-292
- Celiac disease: an immunological jigsaw.Immunity. 2012; 36: 907-919
- HLA-DQ relative risks for coeliac disease in European populations: a study of the European Genetics Cluster on Coeliac Disease.Tissue Antigens. 2004; 63: 562-567
- On the HLA-DQ(alpha 1*0501, beta 1*0201)-associated susceptibility in celiac disease: a possible gene dosage effect of DQB1*0201.Tissue Antigens. 1993; 41: 173-177
- The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses.Proc Natl Acad Sci U S A. 2003; 100: 12390-12395
- Stratifying risk for celiac disease in a large at-risk United States population by using HLA alleles.Clin Gastroenterol Hepatol. 2009; 7: 966-971
- Risk of pediatric celiac disease according to HLA haplotype and country.N Engl J Med. 2014; 371: 42-49
- A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21.Nat Genet. 2007; 39: 827-829
- Gene map of the extended human MHC.Nat Rev Genet. 2004; 5: 889-899
- Concordance, disease progression, and heritability of coeliac disease in Italian twins.Gut. 2006; 55: 803-808
- Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease.Nat Genet. 2011; 43: 1193-1201
- Understanding celiac disease by genomics.Trends Genet. 2016; 32: 295-308
- From genome-wide association studies to disease mechanisms: celiac disease as a model for autoimmune diseases.Semin Immunopathol. 2012; 34: 567-580
- Differences in the risk of celiac disease associated with HLA-DQ2.5 or HLA-DQ2.2 are related to sustained gluten antigen presentation.Nat Immunol. 2009; 10: 1096-1101
- MHC class II proteins and disease: a structural perspective.Nat Rev Immunol. 2006; 6: 271-282
- Integration of genetic and immunological insights into a model of celiac disease pathogenesis.Annu Rev Immunol. 2011; 29: 493-525
- Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients.J Exp Med. 1993; 178: 187-196
- Coeliac disease.Lancet. 2009; 373: 1480-1493
- Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease.Nat Med. 1998; 4: 713-717
- Identification of a gliadin T-cell epitope in coeliac disease: general importance of gliadin deamidation for intestinal T-cell recognition.Scand J Immunol. 1998; 48: 111-115
- Celiac disease: antibody recognition against native and selectively deamidated gliadin peptides.Clin Chem. 2001; 47: 2023-2028
- Antibody responses to deamidated gliadin peptide show high specificity and parallel antibodies to tissue transglutaminase in developing coeliac disease.Clin Exp Immunol. 2007; 150: 285-293
- IgA anti-endomysium antibody. A new immunological marker of dermatitis herpetiformis and coeliac disease.Br J Dermatol. 1984; 111: 395-402
- Accuracy of diagnostic antibody tests for coeliac disease in children: summary of an evidence report.J Pediatr Gastroenterol Nutr. 2012; 54: 229-241
- Endomysial antibodies predict celiac disease irrespective of the titers or clinical presentation.World J Gastroenterol. 2012; 18: 2511-2516
- Endomysial antibody: is it the best screening test for coeliac disease?.Gut. 1992; 33: 1633-1637
- Identification of tissue transglutaminase as the autoantigen of celiac disease.Nat Med. 1997; 3: 797-801
World gastroenterology organisation global guidelines - celiac disease. World Gastroenterology Organisation; 2016. Available at: http://www.worldgastroenterology.org/UserFiles/file/guidelines/celiac-disease-english-2016.pdf. Accessed July 3, 2018.
- ACG clinical guidelines: diagnosis and management of celiac disease.Am J Gastroenterol. 2013; 108 ([quiz: 677]): 656-676
- European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease.J Pediatr Gastroenterol Nutr. 2012; 54: 136-160
- Celiac disease and HLA typing using real-time PCR with melting curve analysis.Tissue Antigens. 2011; 78: 31-37
- Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies.Lancet Gastroenterol Hepatol. 2017; 2: 479-493
Article info
Publication history
Published online: October 05, 2018
Footnotes
Disclosure Statement: The authors have nothing to disclose.
Identification
Copyright
© 2018 Elsevier Inc. All rights reserved.
